Skip to main content
Equibles
CDNA logo

CDNA · CareDx, Inc. · Metrics

Track CDNA — free

Use CDNA with AI

Ask our own analyst here, or connect this data to the AI you already use.

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

Claude ChatGPT Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
$50.31 -0.57 (-1.12%) At close · Sep 8
Russell 2000 member Rebalance outlook locked
Market Cap
$2.61B
Shares
51.73M

CDNA metrics

76 of 115 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$50.31
Market cap
$2.61B

Price action

20 metrics
Price change (1W)
+2.2%
Price change (30D)
+8.1%
Price change (3M)
+128.7%
Price change (6M)
+184.4%
Price change (YTD)
+170.1%
Price change (1Y)
+288.4%
Trailing year
Price change (5Y)
-32.5%
52-week high
$52.36
52-week low
$13.10
Change from 52-week high
-2.8%
Change from 52-week low
+288.4%
Annualized volatility
71.6%
Annualized volatility (3M)
91.7%
Beta
1.4
RSI (14D)
65.5
Price vs SMA 50
+25.0%
Price vs SMA 200
+103.0%
Avg volume (3M)
1.12M
Relative volume
1.2
Average dollar volume
$43.14M

Company

3 metrics
Sector
Healthcare
Industry
Diagnostics & Research
Shares outstanding
51.73M

Valuation

12 metrics
P / E (TTM)
24.6
Trailing earnings · reciprocal yield 4.1%
PEG ratio
—
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
5.7×
reciprocal yield 17.6%
P / book
6.1
reciprocal yield 16.3%
FCF yield
—
TTM · current market cap
Buyback yield
1.9%
P / FCF
—
P / operating cash flow
27.8
reciprocal yield 3.6%
Earnings yield
4.3%

Historical valuation

8 metrics
P / E historical average (3Y)
16.2×
reciprocal yield 6.2%
P / E historical average (5Y)
16.2×
reciprocal yield 6.2%
EV / revenue historical average (3Y)
2.3×
reciprocal yield 43.9%
EV / revenue historical average (5Y)
8.0×
reciprocal yield 12.5%
EV / EBIT historical average (3Y)
14.1×
reciprocal yield 7.1%
EV / EBIT historical average (5Y)
14.1×
reciprocal yield 7.1%
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
1.9%
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-07-30

Profitability

9 metrics
Gross margin
—
Operating margin
23.6%
Trailing 12 months
Net margin
24.2%
Gross profit (TTM)
$98.19M
Operating profit (TTM)
$108.14M
Net income (TTM)
$111.01M
Trailing 12 months
Diluted EPS (TTM)
$2.07
FCF margin
—
Effective tax rate
3.6%

Per share

11 metrics
Revenue per diluted share (TTM)
—
Gross profit per diluted share (TTM)
$2.28
Operating profit per diluted share (TTM)
—
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
—
Operating cash flow per diluted share (TTM)
—
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
—
Book value per share
$-149.08

Growth

11 metrics
Revenue growth YoY
+52.2%
Year over year
Net income growth YoY
-140.6%
Revenue (TTM)
$458.09M
Trailing 12 months
EPS growth YoY
-143.0%
Shares change YoY
-1.6%
Year over year · fewer shares
Revenue CAGR (3Y)
+5.7%
Revenue CAGR (5Y)
+14.6%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
26.1%
Return on assets
20.8%
Debt / equity
—
Current ratio
4.6
EBITDA (TTM)
$122.54M
Free cash flow (TTM)
—
Quick ratio
4.5
Interest coverage
—
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Cash & equivalents
$373.64M
Total assets
$532.99M
Total debt
—

Cash flow & spend

7 metrics
Operating cash flow (TTM)
$93.66M
Capital expenditures (TTM)
$1.93M
R&D (TTM)
$79.87M
SG&A (TTM)
—
Stock compensation (TTM)
$36.97M
R&D / revenue
17.4%
Stock compensation / revenue
8.1%

Ownership (13F)

3 metrics
13F filers
228
13F filer change QoQ
+37
Institutional ownership
102.2%

Short interest

3 metrics
Short interest
11.2%
Latest settlement · 5.0 days to cover
Days to cover
5.0d
Short-squeeze score
78 / 100

Insider activity

2 metrics
Net insider buying (90D)
−$11.81M
Insider-sentiment score
21 / 100

Risk flags

1 metrics
Going concern
—
Key facts CIK 1217234 CUSIP 14167L103 13F (30d) 161 filings 160 filers Visit website Investor relations